English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

One of the most urgent and important tasks of modern biological and medical research is the search and research  of pharmacological agents that combine lipid-lowering and antithrombotic effects in the organism. The unique effects  of the regulatory peptides of the oxoproline series (5-oхo-Pro-His-Pro-NH2, 5-oxo-Pro-Trp-Pro and 5-oxo-Pro-Arg-Pro  or 5-oхo-Pro-His-Pro-NH2, Pyr-Trp-Pro and Pyr-Arg-Pro) have been found in rats with hypercholesterolemia  (metabolic syndrome). Multiple intranasal of these peptides to animals with developed hypercholesterolemia  increased anticoagulant, fibrinolytic and antiplatelet potential of the blood and simultaneously lowered increased  concentrations of total cholesterol, low-density lipoprotein cholesterol and triglycerides. In addition, they  contributed to the normalization of blood glucose levels. A week after the last admistration of these peptides,  the hypocholesterolemic, normoglycemic and anticoagulant effects persisted. The relationship between the structure  of peptides of the oxoproline series and their functional properties is discussed. A conclusion is made  about the prospects of further studies of oxoproline peptides as drugs that combine antithrombotic effects with  the improvement of fat metabolism in the body.

Oxoprolinic short peptides – potential pharmacological means of hypolidemic and antitrombotic actions